糖尿病足指导系统(SOPeD)预防和治疗糖尿病周围神经病变患者足部肌肉骨骼功能障碍的随机对照试验研究方案:FOotCAre(FOCA)试验I
本研究为一项随机、对照、平行两臂、盲法评估的试验方案,拟纳入62例糖尿病周围神经病变(DPN)患者,比较基于SOPeD的定制化家庭运动干预(每周3次、共12周)与仅接受国际共识推荐足部护理的对照组的疗效。主要结局为DPN症状和严重程度分类,次要结局包括步态生物力学、足部感觉、力量与功能平衡等,评估时间点为基线、12周和24周随访。
要点
- SOPeD是一种可定制的康复技术,用于DPN患者足部肌肉强化自我管理。
- 试验计划纳入62例DPN患者,随机分为干预组和对照组。
- 主要结局为DPN症状和严重程度分类,评估时间点为基线、12周和24周。
核心结论
- 该试验旨在探究SOPeD对DPN状态、功能结局和步态生物力学的影响。
研究设计与样本
- 随机、对照、平行两臂试验,盲法评估,计划纳入62例DPN患者。
主要发现
- 原文未报告试验结果,仅描述研究方案。
关键数值与推荐
- 干预组通过SOPeD在家进行运动,每周3次,持续12周,运动方案根据参与者自报的感知用力量表进行定制。
- 对照组接受国际共识推荐的足部护理,不进行足部运动。
- 主要结局为DPN症状和严重程度分类;次要结局包括步态中足踝运动学与动力学及足底压力分布、触觉和振动敏感性、足部健康和功能、足部力量以及功能平衡。
- 评估时间点为基线、12周(完成时)和24周(随访)。
临床怎么用
- 若证实有效,该免费康复技术计划在巴西公共卫生系统中推广。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study is part of a series of two clinical trials. Taking into account the various musculoskeletal alterations of the foot and ankle in people with diabetic peripheral neuropathy (DPN) and the need for self-care to avoid more serious dysfunctions and complications, a self-manageable exercise protocol that focuses on strengthening the foot muscles is presented as a potentially effective preventive method for foot and gait complications. The aim of this trial is to investigate the effect of a customized rehabilitation technology, the Diabetic Foot Guidance System (SOPeD), on DPN status, functional outcomes and gait biomechanics in people with DPN. METHODS/DESIGN: Footcare (FOCA) trial I is a randomized, controlled and parallel two-arm trial with blind assessment. A total of 62 patients with DPN will be allocated into either a control group (recommended foot care by international consensus with no foot exercises) or an intervention group (who will perform exercises through SOPeD at home three times a week for 12 weeks). The exercise program will be customized throughout its course by a perceived effort scale reported by the participant after completion of each exercise. The participants will be assessed at three different times (baseline, completion at 12 weeks, and follow-up at 24 weeks) for all outcomes. The primary outcomes will be DPN symptoms and severity classification. The secondary outcomes will be foot-ankle kinematics and kinetic and plantar pressure distribution during gait, tactile and vibration sensitivities, foot health and functionality, foot strength, and functional balance. DISCUSSION: As there is no evidence about the efficacy of rehabilitation technology in reducing DPN symptoms and severity or improving biomechanical, clinical, and functional outcomes for people with DPN, this research can contribute substantially to clarifying the therapeutic merits of software interventions. We hope that the use of our application for people with DPN complications will reduce or attenuate the deficits caused by DPN. This rehabilitation technology is freely available, and we intend to introduce it into the public health system in Brazil after demonstrating its effectiveness. TRIAL REGISTRATION: ClinicalTrials.gov, NCT04011267. Registered on 8 July 2019.
引用
- Ferreira JSSP, Cruvinel Junior RH, Silva EQ, et al. Study protocol for a randomized controlled trial on the effect of the Diabetic Foot Guidance System (SOPeD) for the prevention and treatment of foot musculoskeletal dysfunctions in people with diabetic neuropathy: the FOotCAre (FOCA) trial I. Trials. 2020. PMID: 31931855. doi:10.1186/s13063-019-4017-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。